We are a small, close-knit and enthusiastic team focused on the development and understanding of catalytic methodologies. Our overarching goal is to introduce operationally simple methods for use by academic and industry that use non-toxic, environmentally benign and inexpensive reagents and catalysts. Underpinning this is a keen interest in mechanism and organometallic chemistry. We have active research programmes in 1st-row transition metal catalysis (Ti, Mn and Fe), group 13 catalysis (B and Al) and accessing low oxidation-state species using non-organometallic activators (Mn, Fe, Co). We are grateful to the Royal Society, EPSRC, AstraZeneca, and GlaxoSmithKline who currently support our research.